Cibus develops gene-edited plant traits using gene editing technologies to address agricultural productivity and sustainability challenges. The company operates across two primary business areas: productivity traits that enable farmers to achieve higher yields while reducing dependence on crop protection chemicals and fertilizers, and sustainable ingredients that allow corporations to replace fossil fuel-based inputs or ingredients whose production generates significant greenhouse gas emissions.
The company licenses its gene-edited traits to agricultural and food industry partners rather than developing end-consumer products directly. This licensing model allows Cibus to monetize its biotechnology platform across multiple crop types and applications without requiring significant downstream commercialization infrastructure.
Based in San Diego, California, Cibus operates with a workforce of 157 full-time employees. The company was founded in 2001 and rebranded from Calyxt, Inc. to Cibus, Inc. in June 2023. As a publicly traded company on Nasdaq with a market capitalization of approximately $0.2 billion, Cibus represents a smaller-scale player within the agricultural biotechnology sector.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-10.83 | $-10.83 | +58.3% | |
| 2023 | $-25.95 | $-25.95 | -6913.5% | |
| 2022 | $-0.37 | $-0.37 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-20 | 0001628280-25-014139 | SEC ↗ |
| 2023-12-31 | 2024-03-21 | 0001628280-24-012546 | SEC ↗ |
| 2022-12-31 | 2023-03-02 | 0001193125-23-058346 | SEC ↗ |
| 2021-12-31 | 2022-03-03 | 0000950170-22-002808 | SEC ↗ |
| 2020-12-31 | 2021-03-04 | 0001564590-21-010976 | SEC ↗ |
| 2019-12-31 | 2020-03-05 | 0001564590-20-008777 | SEC ↗ |
| 2018-12-31 | 2019-03-12 | 0001193125-19-071191 | SEC ↗ |
| 2017-12-31 | 2018-03-14 | 0001193125-18-080923 | SEC ↗ |